These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 35963192)

  • 21. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling.
    Kaur M; Velmurugan B; Tyagi A; Agarwal C; Singh RP; Agarwal R
    Neoplasia; 2010 May; 12(5):415-24. PubMed ID: 20454513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRPM8 indicates poor prognosis in colorectal cancer patients and its pharmacological targeting reduces tumour growth in mice by inhibiting Wnt/β-catenin signalling.
    Pagano E; Romano B; Cicia D; Iannotti FA; Venneri T; Lucariello G; Nanì MF; Cattaneo F; De Cicco P; D'Armiento M; De Luca M; Lionetti R; Lama S; Stiuso P; Zoppoli P; Falco G; Marchianò S; Fiorucci S; Capasso R; Di Marzo V; Borrelli F; Izzo AA
    Br J Pharmacol; 2023 Jan; 180(2):235-251. PubMed ID: 36168728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway.
    Wang Y; Bao X; Zhao A; Zhang J; Zhang M; Zhang Q; Ma B
    Life Sci; 2018 Aug; 207():532-549. PubMed ID: 29972765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wnt signaling modulator DKK4 inhibits colorectal cancer metastasis through an AKT/Wnt/β-catenin negative feedback pathway.
    Liang J; Sun L; Li Y; Liu W; Li D; Chen P; Wang X; Hui J; Zhou J; Liu H; Cao T; Pang M; Guo M; Wang X; Zhao X; Lu Y
    J Biol Chem; 2022 Nov; 298(11):102545. PubMed ID: 36181792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Berberine suppresses colorectal cancer by regulation of Hedgehog signaling pathway activity and gut microbiota.
    Sun Q; Yang H; Liu M; Ren S; Zhao H; Ming T; Tang S; Tao Q; Chen L; Zeng S; Duan DD; Xu H
    Phytomedicine; 2022 Aug; 103():154227. PubMed ID: 35679795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ChanLingGao alleviates intestinal mucosal barrier damage and suppresses the onset and progression of Colorectal cancer in AOM/DSS murine model.
    Tian TT; Chen G; Sun K; Wang XY; Liu Y; Wang FQ; Yang B; Liu J; Han JY; Tang DX
    Int Immunopharmacol; 2024 Dec; 143(Pt 1):113193. PubMed ID: 39368132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCAP31 is involved in modulating colorectal cancer cell proliferation via the Emerin/β-catenin axis.
    Han L; Shi J; Zhao L; Deng J; Li Y; Zhao H; Wang H; Yan Y; Zou F
    Exp Cell Res; 2022 Sep; 418(1):113265. PubMed ID: 35716785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway.
    Monin MB; Krause P; Stelling R; Bocuk D; Niebert S; Klemm F; Pukrop T; Koenig S
    J Surg Res; 2016 Jun; 203(1):193-205. PubMed ID: 27338550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
    Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
    Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cetuximab inhibits colorectal cancer development through inactivating the Wnt/β-catenin pathway and modulating PLCB3 expression.
    Zhang X; Zhou W; Wu C; Jiang J; Guo Q; Feng L; Cheng X; Zhang X
    Sci Rep; 2024 May; 14(1):10642. PubMed ID: 38724565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B-cell translocation gene 3 overexpression inhibits proliferation and invasion of colorectal cancer SW480 cells via Wnt/β-catenin signaling pathway.
    Mao D; Qiao L; Lu H; Feng Y
    Neoplasma; 2016; 63(5):705-16. PubMed ID: 27468874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pimozide suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling pathway.
    Ren Y; Tao J; Jiang Z; Guo D; Tang J
    Life Sci; 2018 Sep; 209():267-273. PubMed ID: 30107167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells.
    Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC
    Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ARHGAP25: A negative regulator of colorectal cancer (CRC) metastasis via the Wnt/β-catenin pathway.
    Tao L; Zhu Y; Gu Y; Zheng J; Yang J
    Eur J Pharmacol; 2019 Sep; 858():172476. PubMed ID: 31228451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNF6 promotes colorectal cancer invasion and migration via the Wnt/β-catenin pathway by inhibiting GSK3β activity.
    Li Q; Wang G; Tao J; Chen W
    Pathol Res Pract; 2021 Sep; 225():153545. PubMed ID: 34352441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m
    Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C
    Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DCZ0415, a small-molecule inhibitor targeting TRIP13, inhibits EMT and metastasis via inactivation of the FGFR4/STAT3 axis and the Wnt/β-catenin pathway in colorectal cancer.
    Agarwal S; Afaq F; Bajpai P; Kim HG; Elkholy A; Behring M; Chandrashekar DS; Diffalha SA; Khushman M; Sugandha SP; Varambally S; Manne U
    Mol Oncol; 2022 Apr; 16(8):1728-1745. PubMed ID: 35194944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sanguisorba officinalis L. suppresses 5-fluorouracil-sensitive and-resistant colorectal cancer growth and metastasis via inhibition of the Wnt/β-catenin pathway.
    Zhang W; Peng C; Yan J; Chen P; Jiang C; Sang S; Yuan Y; Hong Y; Yao M
    Phytomedicine; 2022 Jan; 94():153844. PubMed ID: 34785413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
    Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM
    Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity.
    Noah TK; Lo YH; Price A; Chen G; King E; Washington MK; Aronow BJ; Shroyer NF
    Gastroenterology; 2013 May; 144(5):1012-1023.e6. PubMed ID: 23376423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.